Ros Cutts
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Oncology top 5%
- PARP inhibition in cancer therapy
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
Papers in
-
- Cancer Genomics and Diagnostics 4
- Genetics 3
- Estrogen and related hormone effects 2
- BRCA gene mutations in cancer 1
- Co-authors
- Nicholas C. Turner (3 shared papers)Lisa Crocker (1 shared paper)Jennifer Arca Lacap (1 shared paper)Matthew Beaney (1 shared paper)María Teresa Herrera-Abreu (1 shared paper)Deepak Sampath (1 shared paper)Jennifer Margaret Giltnane (1 shared paper)Chris Bakal (1 shared paper)
- Journals
- Clinical Cancer Research (2 papers)Nature Communications (2 papers)Cancer Discovery (1 paper)Annals of Oncology (1 paper)Cancers (1 paper)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Ros Cutts
9 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 63
- Cancer Research 569
- Oncology 669
- Pulmonary and Respiratory Medicine 474
- Reproductive Medicine 62
- Molecular Biology 513
Countries citing papers authored by Ros Cutts
This map shows the geographic impact of Ros Cutts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ros Cutts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ros Cutts more than expected).
Fields of papers citing papers by Ros Cutts
This network shows the impact of papers produced by Ros Cutts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ros Cutts. The network helps show where Ros Cutts may publish in the future.
Co-authors
The 25 scholars most cited alongside Ros Cutts, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 295 | |
| 2 | 2016 | 240 | |
| 3 | 2017 | 224 | |
| 4 | 2017 | 207 | |
| 5 | 2020 | 197 | |
| 6 | 2019 | 121 | |
| 7 | 2024 | 25 | |
| 8 | 2018 | 14 | |
| 9 | 2023 | 10 | |
| 10 | 2026 | 0 |
About Ros Cutts
Ros Cutts is a scholar working on Cancer Research, Genetics, Oncology, Pulmonary and Respiratory Medicine and Genetics, having authored 10 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (4 papers), DNA Repair Mechanisms (2 papers), Advanced Breast Cancer Therapies (2 papers), Estrogen and related hormone effects (2 papers), BRCA gene mutations in cancer (1 paper), CRISPR and Genetic Engineering (1 paper), Cervical Cancer and HPV Research (1 paper) and Ferroptosis and cancer prognosis (1 paper). The work is most often cited by research in Cancer Research (569 citations), Oncology (669 citations), Pulmonary and Respiratory Medicine (474 citations), Reproductive Medicine (62 citations) and Molecular Biology (513 citations). Ros Cutts has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Nicholas C. Turner, Lisa Crocker, Jennifer Arca Lacap, Matthew Beaney, María Teresa Herrera-Abreu, Deepak Sampath, Jennifer Margaret Giltnane, Chris Bakal, Alexis R. Barr and Irina S. Babina. Their work appears in journals such as Clinical Cancer Research, Nature Communications, Cancer Discovery, Annals of Oncology and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.